SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 928.61 |
| Enterprise Value ($M) | 877.51 |
| Book Value ($M) | 378.10 |
| Book Value / Share | 3.56 |
| Price / Book | 2.46 |
| NCAV ($M) | 376.01 |
| NCAV / Share | 3.20 |
| Price / NCAV | 2.47 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.69 |
| Return on Assets (ROA) | -0.63 |
| Return on Equity (ROE) | -0.70 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 11.66 |
| Current Ratio | 11.66 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 456.21 |
| Assets | 458.30 |
| Liabilities | 80.19 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rtw Investments, Lp | 7.00 | 32.26 | |
| 13G/A | Janus Henderson Group Plc | 11.40 | -75.42 | |
| 13G/A | Biotechnology Value Fund L P | 6.40 | -10.00 | |
| 13G/A | BlackRock, Inc. | 7.10 | 0.00 | |
| 13G/A | State Street Corp | 3.10 | -39.78 | |
| 13G/A | Suvretta Capital Management, Llc | 7.50 | 63.48 | |
| 13D/A | Ra Capital Management, L.p. | 13.40 | 0.00 | |
| 13G/A | Deep Track Capital, LP | 2.10 | -53.83 | |
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 4.48 | 14.42 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 219,463 | 1,264,766 | 17.35 | |
| 157,891 | 920,715 | 17.15 | |
| 305,078 | 2,574,047 | 11.85 | |
| 138,418 | 779,064 | 17.77 | |
| 119,229 | 429,900 | 27.73 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CVAC – CureVac N.V. | EOLS – Evolus, Inc. |
| ESPR – Esperion Therapeutics, Inc. | ETON – Eton Pharmaceuticals, Inc. |
| FATE – Fate Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io